Blood vessels are not static pipes. During development, and indeed whenever tissues grow or repair themselves, vascular networks must be extensively remodeled: new sprouts extend into avascular territory, redundant branches regress, and existing vessels adapt their caliber and shape to match the demands of blood flow. In the central nervous system, this orchestration is guided in part by Wnt signaling, a family of pathways with two major branches. The canonical Wnt/β-catenin branch is well established as a regulator of endothelial specialization and of the blood–brain barrier, the selective fortress that shields neural tissue from the bloodstream. The non-canonical Wnt/Planar Cell Polarity (PCP) branch, by contrast, is known to govern vascular remodeling and the ability of endothelial cells to sense and adapt to the mechanical forces of flowing blood. What has remained stubbornly unclear is how the PCP pathway—activated at the cell surface—translates its instructions into the internal polarity machinery that tells a cell which way is forward.

The new study, led by Cécile Duplàa and Thierry Couffinhal of Inserm unit UMR1034 at the University of Bordeaux, with contributions from Alexandre Dubrac at the Sainte-Justine Research Center and Université de Montréal, answers that question by zeroing in on MCC, short for Mutated in Colorectal Cancer. MCC is a PDZ-domain protein, a class of scaffold molecules that physically assemble signaling complexes at specific cellular locations. It had previously been implicated in cell migration in epithelial cells and identified as an effector of non-canonical Wnt signaling during convergence and extension movements in zebrafish embryos—developmental processes that depend intimately on planar cell polarity. The Bordeaux team, building on their laboratory’s long-standing interest in vascular morphogenesis, hypothesized that MCC might perform an analogous role inside endothelial cells.

The researchers’ mechanistic work centered on a striking molecular partnership. Using proximity-dependent biotinylation (BioID), a technique that maps proteins sitting close to a protein of interest within living cells, combined with mass spectrometry proteomics, they found that MCC interacts with CEP131, a component of centriolar satellites. Centriolar satellites are electron-dense granules that cluster around the centrosome—the cell’s principal microtubule-organizing center—and help regulate centrosome function, protein turnover and cilia biology. The team’s proteomics data, deposited in the ProteomeXchange Consortium, show that MCC does not merely associate with CEP131; it actively promotes the satellite protein’s degradation, engaging both the proteasome, the cell’s cytosolic protein-shredding machinery, and autophagy, the lysosomal degradation system often used for bulk recycling of cellular components. In other words, MCC functions as a quality-control switch for the structures surrounding the centrosome.

Why would this matter for polarity? The answer lies in the geometry of a migrating endothelial cell. To move directionally, a cell must establish a front–rear axis: the microtubule cytoskeleton and the microtubule-organizing center must be positioned and oriented toward the leading edge, while the Golgi apparatus and nucleus reposition accordingly. Previous work from several groups, including studies showing that excess centrosomes scatter and derail endothelial migration, had established that centrosome-associated organization is a linchpin of directional movement. By keeping centriolar satellite material in check through regulated turnover, MCC appears to preserve the clean, polarized centrosomal architecture that directional migration demands. When the researchers depleted MCC from endothelial cells, this organization fell apart—and with it, the cells’ ability to polarize front-to-back.

One of the most intriguing findings of the study is what did not fall apart. When the team subjected MCC-depleted endothelial cells to flow, mimicking the shear stress that blood exerts on vessel walls in vivo, the cells still elongated and aligned their cytoskeletons with the direction of flow—indeed, this flow-induced elongation was preserved and even enhanced. This dissociation is biologically revealing. It demonstrates that two processes often lumped together as “endothelial alignment” are mechanistically separable: the passive morphological response to fluid shear, in which cells stretch along the flow axis, can proceed without MCC, while the active, directional front–rear polarization required for guided migration depends on it. For vascular biologists, this functional split offers a new framework for dissecting how vessels respond to hemodynamic forces.

The in vivo evidence came from the postnatal mouse retina, a classic and visually tractable model of angiogenesis in which a vascular plexus expands radially across the retinal surface during the first weeks of life, driven by proliferating “tip” cells at the angiogenic front. When the researchers deleted the Mcc gene specifically in endothelial cells of newborn mice, the retinal vasculature failed to remodel properly. Vessel density was abnormal, endothelial proliferation dropped, and—critically—the front–rear polarity of endothelial cells at the angiogenic front was disrupted. Tip cells, which must polarize and migrate persistently to lead the vascular sprout, lost their organizational bearings.

To rule out the possibility that these polarity defects were merely secondary consequences of a grossly malformed vasculature, the team employed an elegant pharmacological intervention. Captopril, an angiotensin-converting enzyme inhibitor long used as a blood pressure drug, is known to normalize vascular density and promote vessel regression in the remodeling retina. When the researchers treated the MCC-deficient mice with captopril, vascular density normalized and pruning proceeded—but endothelial polarity remained broken. This result is pivotal: it indicates that MCC’s role is cell-intrinsic. The protein is not simply required to generate a vascular environment in which polarity is possible; it is required within each endothelial cell to construct the polarity machinery itself.

The study also situates MCC within a broader signaling hierarchy. Prior work by the Bordeaux group and collaborators had identified the E3 ubiquitin ligase PDZRN3 as a Wnt/PCP pathway component required for vascular morphogenesis, and proteomic analyses had placed PDZRN3 downstream of Wnt5a–Ror signaling, a prototypical non-canonical Wnt cascade. The new findings extend this wiring: MCC now emerges as a downstream effector that converts PCP pathway activity into centrosome-associated proteostasis—the controlled degradation of satellite components—thereby closing the gap between a signal received at the membrane and a polarized cytoskeleton inside the cell.

Beyond developmental biology, the work carries implications for human disease. MCC was originally named for its frequent mutation in colorectal tumors, and it has since been characterized as a putative tumor suppressor that represses β-catenin-dependent transcription. Its newly described role in endothelial biology suggests that alterations in MCC could contribute to vascular pathologies as well. Aberrant angiogenesis and defective vascular remodeling underlie a wide range of conditions, from diabetic retinopathy—where neurovascular crosstalk fails and vessels in the retina deteriorate—to ischemic disease, where therapeutic revascularization is limited by the vessels’ inability to remodel productively. Cerebral small vessel disease, another area of active investigation by members of the consortium, may also intersect with pathways controlling endothelial polarity and mechanosensing. If the MCC–CEP131 axis proves druggable, it could offer a handle for promoting or restraining vascular remodeling in clinical contexts.

The technical breadth of the study is itself noteworthy. The team combined live-cell polarity assays and automated image analysis, single-cell RNA sequencing of mouse retina—data publicly available through the Gene Expression Omnibus under accession GSE175895—and quantitative proteomics to characterize the MCC interactome. Such multi-omics integration is increasingly the norm in vascular biology, where the behavior of a single endothelial cell must be understood simultaneously at the level of gene expression, protein interaction networks and subcellular architecture.

For the field, the study fills a genuine conceptual hole. The Wnt/PCP pathway has been implicated in angiogenesis for nearly two decades, with components such as Celsr1, DAAM1 and Kif26b variously shown to regulate endothelial junctions, proliferation and polarity. Yet the route from pathway activation at the plasma membrane to the microtubule-organizing center has remained speculative. By identifying MCC as the bridge—and by showing that the bridge is built from regulated protein degradation at the centrosome—the Bordeaux-led consortium has supplied both the missing connection and a mechanistic explanation for why it matters. As vascular biologists now probe how this axis operates in pathological angiogenesis and in the mature vasculature of the adult brain, MCC may shed its reputation as merely a cancer gene and take on a new identity: a master organizer of the cell’s sense of direction.

At the heart of this inquiry lie the proteins and signaling pathways that construct and maintain the blood-brain barrier. Research conducted by Mi, Ye, Zhang, and their colleagues uncovers a differentiated expression profile across various demographics, notably between sexes and as influenced by age. Understanding these nuanced disparities is crucial, considering how male and female brains may respond differently to neurological threats, treatments, and recoveries based on hormonal and genetic differences.

The blood-brain barrier itself is composed of endothelial cells, which form tight junctions to restrict the passage of solutes and potential neurotoxins from the bloodstream into the neural tissues. Positioned as a gatekeeper, the BBB plays a crucial role in maintaining homeostatic conditions in the brain, but how these protective mechanisms vary with sex and age remains an underexplored area within neurobiology. The groundbreaking findings of this study not only highlight these variations but also suggest that therapeutic strategies may need to be tailored based on these biological differences.

In their findings, the researchers discuss how estradiol, a form of estrogen, appears to modulate the expression of specific genes linked to the BBB’s efficacy. This modulation suggests that fluctuations in hormone levels, such as those experienced during menstrual cycles, pregnancy, or menopause, could significantly alter the protective functions of the BBB in women. Conversely, the findings also point to age-related declines in these protective mechanisms in both sexes, with particular emphasis on the heightened vulnerability observed in older populations.

Interestingly, the study indicates that the variations are not merely due to hormonal influences but are also linked to distinct genetic markers associated with sex. These genetic determinants pave the way for different response mechanisms in males and females, highlighting the necessity of gender-specific approaches in understanding and treating neurological disorders. This revelation presents an exciting avenue for future research, where identifying these genetic pathways could lead to novel therapeutic interventions tailored to individual genetic profiles.

Moreover, the implications of these findings extend well beyond academic curiosity; they resonate deeply within clinical practices. As neurological conditions such as Alzheimer’s disease and multiple sclerosis continue to pose significant challenges to public health, recognizing the differential expression of BBB regulators could inform treatment modalities. Clinicians may need to consider age and sex not just as simple statistical variables, but as fundamental elements that influence patient outcomes and responses to therapy.

While the complexities of the blood-brain barrier are becoming clearer, challenges remain. One such challenge involves the difficulty of studying this barrier in vivo due to its critical role in preserving cerebrospinal fluid and maintaining brain integrity. The research team has emphasized the importance of developing innovative models that allow for real-time observation of BBB dynamics in living organisms, paving the way for further exploration of how external factors, like inflammation and stress, might interact with these age- and sex-dependent variables.

As the study nears its publication in Biology of Sex Differences, the scientific community eagerly anticipates further discussions surrounding these groundbreaking findings. The researchers aim to catalyze a broader dialogue about the potential for personalized medicine approaches to neurological health; treatments could be specifically designed with consideration for sex and age, ultimately striving for improved efficacy and reduced side effects.

The investigation into the blood-brain barrier’s regulators also raises poignant questions about how environmental factors, lifestyle choices, and other biological mechanisms might influence BBB integrity over a lifetime. Following this research, there is an emerging necessity to dive deeper into how these external variables, including diet and exercise, intersect with biological differences throughout aging and developmental stages.

Furthermore, this study serves as a reminder of the overarching importance of inclusive research practices. Historically, neuroscience studies have often been male-centric, leading to significant gaps in our understanding of female brain biology. By foregrounding the differences in BBB regulation across sexes, this research contributes to a much-needed shift toward a more holistic comprehension of how biology shapes neuroanatomy and neurophysiology differently for men and women.

As the discourse on sex and age differences in the blood-brain barrier continues to evolve, researchers are encouraged to extend these findings into broader studies examining various diseases. Conditions such as stroke, traumatic brain injury, and neuroinflammatory diseases could gain from an insightful focus on BBB regulation, enhancing strategies for prevention and treatment.

In conclusion, the investigation spearheaded by Mi, Ye, Zhang, and their collaborators marks a pivotal advance in understanding the blood-brain barrier’s complexities. The revelations surrounding sex- and age-based differences in its regulators not only illuminate potential therapeutic pathways but also advocate for a more individualized approach to neurological health. With further research, we may indeed uncover tailored interventions that respect the intricate biological tapestry of each individual, leading to breakthroughs in effectively managing neurological conditions across diverse populations.

The pursuit of this research is timely, aligning with ongoing global efforts to enhance our understanding of brain health and disease. As we embark on this next chapter in neurobiology, the connections drawn between sex, age, and blood-brain barrier integrity could redefine how we view and approach neurological health in the years to come.

Subject of Research: Blood-Brain Barrier Regulation and its Variations by Sex and Age

Article Title: Sex- and Age-Differences in the Expression of Critical Blood-Brain Barrier Regulators: A Physiological Context

Article References:

Mi, X., Ye, ZL., Zhang, XJ. et al. Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context.
Biol Sex Differ 16, 67 (2025). https://doi.org/10.1186/s13293-025-00751-2

Image Credits: AI Generated

DOI:

Keywords: blood-brain barrier, sex differences, age differences, neurological health, therapeutic strategies, personalized medicine, neurobiology, BBB regulators, genetic expression, hormones

The study, titled “Endothelial TDP-43 Depletion Disrupts Core Blood-Brain Barrier Pathways in Neurodegeneration,” was led by Omar Moustafa Fathy, a promising MD/Ph.D. candidate working within the UConn Center for Vascular Biology. This work is particularly significant as it showcases the collaborative efforts of Fathy and his team, who worked under the mentorship of Dr. Patrick A. Murphy, an associate professor and interim director of the Center for Vascular Biology. Importantly, the team collaborated with Dr. Riqiang Yan, a well-respected figure in the field of Alzheimer’s research, enhancing the credibility and depth of the findings.

The research sheds light on a critical yet often overlooked aspect of neurodegenerative diseases—vascular dysfunction. The blood-brain barrier is crucial for maintaining central nervous system homeostasis, yet previous studies have primarily concentrated on neuronal damage, neglecting the role of endothelial cells that form the inner lining of blood vessels. Understanding this relationship is paramount, as endothelial cells contribute significantly to the integrity and functionality of the blood-brain barrier.

To investigate this phenomenon, the research team developed a novel methodology that segregates endothelial cells from frozen tissue samples, innovatively using an NIH-sponsored biobank. They employed inCITE-seq, a sophisticated technique that allows for the precise measurement of protein-level signaling in individual cells. This application marked the first time such a method was utilized in human tissues, yielding unprecedented insights into the signaling pathways associated with endothelial cells in neurodegenerative conditions.

One of the critical findings from the study was the depletion of TDP-43, an RNA-binding protein that has been genetically linked to diseases like ALS and FTD and is commonly disrupted in Alzheimer’s disease. Interestingly, this depletion was observed in endothelial cells from patients suffering from these neurodegenerative diseases, suggesting a shared pathological mechanism across diseases that were previously studied independently. This insight directs attention toward a broader understanding of neurodegeneration as a disease process that encompasses vascular components, not just neuronal ones.

Murphy emphasized the implications of these findings, noting the paradigm shift in our understanding of blood vessels. “It’s easy to think of blood vessels as passive pipelines,” he stated. “However, our findings suggest that they actively participate in shaping the disease progression across various neurodegenerative disorders.” The research indicates that the changes observed in endothelial cells are not merely collateral damage but rather integral components of disease pathology. This recognition opens the door for novel therapeutic interventions targeting vascular health.

The collective effort from UConn’s researchers not only breaks ground in the field of neurobiology but also presents potential pathways for the development of new biomarkers. The identification of specific endothelial cell dysfunctions may help in creating diagnostic tools launched from blood samples of patients afflicted by these debilitating diseases, fostering earlier interventions and personalized treatment strategies.

Throughout the study, funding was a critical facilitator to their success. Resources were provided through startup funds from the UConn School of Medicine, along with competitive grants from the NIH’s National Heart, Lung, and Blood Institute and the American Heart Association. These financial supports underscore the importance of backing interdisciplinary research that seeks to bridge gaps across various fields, emphasizing the interconnectedness of vascular biology and neurodegeneration research.

Future studies will likely continue dissecting the complexities surrounding endothelial cell roles in brain health. As advancements in technology and methodology evolve, researchers aim to further characterize and understand how these cells can respond and adapt in the context of neurodegeneration. Some scholars speculate that uncovering these relationships holds the key to breakthroughs in treating or even preventing such conditions.

Ultimately, the research by Fathy, Murphy, and their collaborators presents a compelling narrative of how interdisciplinary work can pave the way for novel insights into longstanding medical challenges. It illustrates a pivotal moment where the study of vascular biology intersects with neurology, fostering a more comprehensive understanding of the mechanisms that contribute to debilitating diseases. The ability to effectively translate these discoveries into clinical applications could revolutionize how we approach neurodegenerative disease management and treatment in the future.

As this crucial research begins to reverberate throughout the scientific community, it sparks discussions about the potential for designing therapies that target vascular aspects directly involved in neurodegeneration. Moving forward, this could change the future of treatments for these complex diseases by moving beyond the traditional neuronal-centric view and incorporating a more holistic approach that considers the intricate relationships within the brain’s microenvironment.

The ongoing dialogue among researchers, clinicians, and academic institutions highlights the importance of continued collaboration in unlocking the mysteries surrounding neurodegenerative diseases. The pursuit of knowledge in this area is relentless, driven by the urgent need to address the growing incidence of these disorders as populations age. Each new finding builds upon previous victories and setbacks in the quest for more effective treatments, aiming to bring hope to those affected by such devastating illnesses.

In summary, the findings from the UConn research team represent an essential step forward in neurology and vascular biology, unveiling how endothelial dysfunction may play an equally pivotal role in neurodegenerative processes alongside neuronal dysfunction. By fostering this integrated perspective, the potential for novel therapeutic interventions broadens, paving the way for improved health outcomes in individuals affected by these chronic conditions.

Subject of Research: Endothelial cells’ role in neurodegenerative diseases
Article Title: Endothelial TDP-43 depletion disrupts core blood-brain barrier pathways in neurodegeneration
News Publication Date: 14-Mar-2025
Web References: https://urldefense.com/v3/__https:/www.nature.com/articles/s41593-025-01914-5__;!!Cn_UX_p3!lNxCmhXLYp-lykv2BZo0-goVYwrwuYaYX2VK66NFCpGEq_ogSxHomGzLCNtOK74e7t209tyD1xXBlYhYUw%24
References: [Not applicable as per instruction]
Image Credits: UConn Health Photo by Tina Encarnacion

Keywords: Endothelial cells, Neurodegenerative diseases, Alzheimer’s disease, Amyotrophic lateral sclerosis, Blood-brain barrier, Vascular biology, Neurodegeneration, TDP-43, Research collaboration, Biomarkers, Disease mechanisms.